GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Sp1 | affects activity | ISO | SP1 (Homo sapiens) | 6480464 | CTD | Doxorubicin affects the activity of SP1 protein | PMID:17108358 | Sp1 | decreases expression | ISO | SP1 (Homo sapiens) | 6480464 | CTD | Doxorubicin results in decreased expression of SP1 mRNA | PMID:29803840 | Sp1 | increases ribosylation | ISO | SP1 (Homo sapiens) | 6480464 | CTD | Doxorubicin results in increased ribosylation of SP1 protein | PMID:22293659 | Sp1 | multiple interactions | ISO | SP1 (Homo sapiens) | 6480464 | CTD | [Doxorubicin results in increased ribosylation of SP1 protein] affects the reaction [SP1 protein binds to TOP2A promoter]; Doxorubicin promotes the reaction [SP1 protein binds to BIRC5 promoter]; Doxorubicin promotes the reaction [SP1 protein binds to ESR1 promoter]; Doxorubicin promotes the reaction [TP53 protein binds to SP1 protein] | PMID:17124180 PMID:19351845 PMID:22293659 | |
Go Back to source page | Continue to Ontology report |